Enlivex Therapeutics Ltd. submitted an amendment to their previous filing on September 11, 2024, to include the Amended and Restated Compensation Policy for Company Office Holders, which is part of the proxy statement for their Annual General Meeting on October 31, 2024. This amendment does not change any other information from the original filing or reflect events after that date.